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Safety of endoscopic retrograde cholangiopancreatography 
(ERCP) in pregnancy: A systematic review and meta‑analysis
Mohamed Azab, Shishira Bharadwaj, Mahendran Jayaraj1, Annie S. Hong2, Pejman Solaimani, 
Mohamad Mubder2, Hyeyoung Yeom3, Ji Won Yoo2, Michael L. Volk
Department of Gastroenterology and Hepatology, Loma Linda University Medical Center, California, Departments of 1Gastroenterology 
and 2Internal Medicine, 3School of Community Health Sciences, University of Nevada Las Vegas, Las Vegas, Nevada, USA
Systematic Review/Meta-analysis
Background/Aims: Endoscopic retrograde cholangiopancreatography (ERCP) is a technically challenging 
procedure rarely associated with severe postprocedure complications. Hormonal changes during pregnancy 
promote cholelithiasis, but there are limited clinical data available on the outcomes of ERCP in pregnant 
women. ERCP techniques without irradiation were recently introduced as potential alternative. We performed 
a systematic review and meta‑analysis to assess the safety of ERCP in pregnancy and to compare outcomes 
of radiation versus nonradiation ERCP.
Materials and Methods: A systematic search of PubMed, Medline/Ovid, Web of Science, and Google Scholar 
through April 18th, 2018 using PRISMA and MOOSE guidelines identified 27 studies reporting the outcomes 
of ERCP in pregnancy. Random effects pooled event rate and 95% confidence intervals (CIs) were estimated. 
Heterogeneity was measured by I2, and meta‑regression analysis was conducted. Adverse outcomes were 
divided into fetal, maternal pregnancy‑related, and maternal nonpregnancy‑related.
Results: In all, 27 studies reporting on 1,307 pregnant patients who underwent ERCP were identified. 
Median age was 27.1 years. All results were statistically significant (P < 0.01). The pooled event rate 
for overall adverse outcomes was 15.9% (95% CI = 0.132–0.191) in all studies combined, 17.6% (95% 
CI = 0.109–0.272) in nonradiation ERCP (NR‑ERCP) subgroup and 21.6% (95% CI = 0.154–0.294) 
in radiation ERCP subgroup. There was no significant difference in the pooled event rate for fetal 
adverse outcomes in NR‑ERCP 6.2% (95% CI = 0.027–0.137) versus 5.2% (95% CI = 0.026–0.101) in 
radiation ERCP group. There was no significant difference in maternal pregnancy‑related adverse 
outcome event rate between NR‑ERCP (8.4%) (95% CI = 0.038–0.173) and radiation ERCP (7.1%) (95% 
CI  =  0.039–0.125). Maternal nonpregnancy‑related adverse outcome event rate in NR‑ERCP was 
7.6% (95% CI = 0.038–0.145), which was half the event rate in radiation ERCP group of 14.9% (95% 
CI = 0.102–0.211).
Conclusions: ERCP done by experienced endoscopists is a safe procedure during pregnancy. Radiation‑free 
techniques appear to reduce the rates of nonpregnancy‑related complications, but not of fetal and 
pregnancy‑related complications.
Keywords: Endoscopic retrograde cholangiopancreatography,  gallstones, pregnancy
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INTRODUCTION
Physiologic changes during pregnancy are known 
to predispose to biliary disease.[1,2] High levels of  
estrogen stimulate hepatic production and secretion of  
cholesterol.[3,4] Rising progesterone also delays emptying 
of  the gallbladder, which causes bile stasis and slows the 
release of  bile acids that bind cholesterol.[3,4] Together, 
these lead to the development of  cholesterol gallstones. 
This risk is higher with each pregnancy, and multiparous 
women are 10  times more likely to develop biliary 
complications [Figure  1].[5] In a prospective study of  
3,200 pregnant women without cholelithiasis on baseline 
abdominal ultrasound  (US), new cholelithiasis or bile 
sludge was observed in 7.1% at second trimester, 7.9% at 
third trimester, and up to 10.2% at 6 weeks postpartum.[6] 
Of  these, about 1.2% developed symptoms, and 10% of  
those with symptoms later developed serious complications 
such as acute cholecystitis, cholangitis, symptomatic 
choledocholithiasis, biliary strictures, or biliary pancreatitis 
that would necessitate therapeutic intervention.[6,7]
Although the physiology of  pregnancy itself  increases 
the risk of  biliary pathology, the management of  these 
conditions in this patient population is poorly studied 
thus far. The mainstay in biliary intervention is endoscopic 
retrograde cholangiopancreatography  (ERCP), which is 
therapeutic for many of  these diseases.[8] In addition to the 
usual risks associated with ERCP, some inherent concerns 
arise in a pregnant female, including but not limited to 
exposure to radiation, medication teratogenicity, anesthesia, 
and changes in maternal anatomy.[3] The specific relative 
risks of  these effects are not well established because current 
case studies are limited by small sample size. As opposed 
to esophagogastroduodenoscopy (EGD) or colonoscopy, 
ERCP requires real‑time prolonged X‑ray with significant 
amount of  fluoroscopic radiation, which is a potential 
cause of  developmental complications in utero. One study 
with 15 patients showed that on average, fluoroscopy time 
was 3.2 min [standard deviation (SD) ± 1.8 min] with total 
3.1 millisievert (mSV) (SD ± 1.64 mSV) of  radiation; in 
general, it is recommended during first trimester to limit 
exposure to less than 1 mSV, and over the entire pregnancy 
less than 5 mSV.[4]
Another concern is that the usual medications for sedation 
used during endoscopy are poorly studied in pregnant 
women. The most commonly used agents are propofol and 
ketamine.[9,10] Both drugs at moderate doses are category B 
drugs and considered relatively safe to use in pregnancy due 
to rapid onset and short duration of  effect.[9,10] Of  note, 
they require strict monitoring of  levels by an experienced 
anesthesiologist and have not been well studied during first 
trimester pregnancy.[9] Other commonly used endoscopy 
agents such as benzodiazepines, meperidine, and narcotics 
are usually avoided due to their lower threshold for causing 
fetal neurobehavioral depression and potential birth 
defects.[4,9] Finally, the usual post‑ERCP adverse outcomes 
including postsphincterotomy bleeding  (PSB), infection, 
pancreatitis, and perforation can have greater consequences 
in a pregnant woman.[3] Even less documented are any 
potential causal links between ERCP and induction of  
early labor, premature rupture of  membranes, or even 
spontaneous abortion.[11]
Due to these concerns and the precarious nature of  
pregnancy itself, ERCP has historically been avoided in 
pregnancy. With the elevated risk of  biliary disease that can 
occur in this patient population, avoidance of  therapeutic 
measures can also become a cause of  significant morbidity 
and mortality.[3] Currently, the management of  these 
complications is poorly defined, and each case is decided 
on an individual basis – which can lead to clinician bias 
and postponement of  critical care. Misunderstanding and 
misrepresentation of  best standard of  practice can lead 
to recurrent pain symptoms, high emergency department 
visits, more frequent hospitalization, or even death.[12] Fear 
of  intervention stems from lack of  access to information 
about the exact benefits versus risks. Available studies 
are few and scattered, so here we present a meta‑analysis 
of  retrospective case studies on ERCP in pregnancy to 
compare outcomes, establish methods to minimize risk 
of  the procedure, and have better understanding of  the 
procedure outcomes that can be used by gastroenterologists 
and physicians in future patient care.
MATERIALS AND METHODS
Search strategy
We performed a literature search using the keywords “ERCP,” 
“endoscopic retrograde cholangiopancreatography,” Figure 1: Pathophysiology of gallstone formation in pregnancy
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“pregnancy,” “endoscopy,” and “fluoroscopy” in various 
combinations to identify original studies published in 
English from PubMed, Medline/Ovid, Cumulative Index 
to Nursing and Allied Health Literature (CINAHL), Web 
of  Science, and Google Scholar databases, through April 
18th, 2018.
Inclusion and exclusion criteria
We included studies that reported outcomes of  pregnant 
patients who underwent ERCP. We excluded studies that 
reported other endoscopic procedures in pregnancy.
Study selection and data extraction
Two authors (M.A. and M.J.) independently screened titles 
and abstracts. They obtained full articles that met the 
inclusion and exclusion criteria, and after an independent 
review, they extracted the data. For all phases, discrepancies 
were resolved in consultation with two other authors (M.M. 
and A.H.). We also hand‑searched the eligible articles. 
Forty‑seven studies relevant to inclusion criteria were 
added. The actual numbers of  ERCP cases were collected 
from tables and manuscript text in each study. When actual 
data were not presented in certain studies, two authors (J.Y. 
and M.A.) directly contacted the corresponding authors 
of  their studies to obtain the data. Since data were from 
previously published studies, an institutional review board 
approval was waived. Finally, 27 studies were selected. 
Figure 2 presents the study selection process in accordance 
with the Preferred Reporting Items for Systematic Reviews 
and Meta‑Analyses (PRISMA) statement.[13] A summary of  
studies is shown in Table 1.[11,14‑39]
Study outcomes
We divided outcomes of  ERCP in pregnancy into three 
categories. First, fetal outcomes, which included any fetal 
adverse outcomes reported during pregnancy, labor, or 
the follow‑up period like intrauterine growth retardation, 
congenital malformations, fetal demise, and low birth weight. 
Second, maternal pregnancy‑related outcomes, which 
included any pregnancy adverse outcomes reported after the 
ERCP procedure such as preterm labor, preeclampsia, or 
bleeding. Third, maternal nonpregnancy‑related outcomes, 
which included all ERCP‑related adverse outcomes 
that are not related to pregnancy, such as post‑ERCP 
pancreatitis (PEP), PSB, or cholecystitis.
Quality assessment
We used the Newcastle–Ottawa Scale (NOS) to assess the 
risk of  bias in the included studies.[40,41] Risk of  bias in 
relation to selection, comparability, and assessment of  the 
exposure/outcome was assessed according to nine items 
using a star allocation scheme. Stars were allocated if  a 
study was deemed to have a low risk of  bias within each 
item, according to the coding manual provided.[42] A study 
was categorized as being of  low risk of  bias if  a total of  
8–9 stars were allocated, medium risk of  bias if  6–7 stars 
were allocated, and of  high risk of  bias if  the study was 
given ≤5 stars.
Studies identified through PubMed, 
Medline/Ovid, CINAHL, Web of 
Science, and, Google Scholar 





















Studies excluded by title 
and abstract (n = 193)













Figure 2: Study selection process
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Data synthesis and analysis
We combined individual study results to calculate the 
pooled odds ratio (OR) and 95% confidence intervals (CIs) 
using the random effects method.[43] Between‑study 
heterogeneity was assessed using the I2 static values of  
50%, representing extensive statistical inconsistency. 
Subgroup analysis was performed to examine effects of  
irradiation on fetal and maternal outcomes. All analyses 
were performed using Comprehensive Meta‑Analysis 
version  3  (Biostat Inc., Englewood, NJ, USA; 2014). 
A  two‑sided P  value  <0.05 was considered statistically 
significant.
RESULTS
A total of  1,307  patients from 27 retrospective studies 
were analyzed. Baseline characteristics from pooled study 
participants are reported in Table  1. The characteristics 
were grouped by adverse outcomes  (fetal, maternal 
pregnancy‑related, and maternal nonpregnancy‑related): 
fetal adverse outcomes (n = 9), maternal pregnancy‑related 
outcomes  (n  =  22), maternal nonpregnancy‑related 
outcomes (n = 143).
Figure 3 presents the meta‑analysis results of  the overall 
adverse events in pregnant patients; the pooled event 
rate was 15.9% (95% CI = 0.132–0.19). The results were 
statistically significant  (P  <  0.01). Heterogeneity was 
low (Q = 26, P = 0.370, I2 = 6.3%). Inamdar et al.’s study 
could be an outlier resulting in increasing the degree of  
heterogeneity.[16] When this study was removed from 
current meta‑analysis, the magnitude of  pooled event rate 
slightly increased to 18.1%  (95% CI 0.144–0.226) and 
heterogeneity dropped to near zero (I2 < 0.01%).
The large number of  patients in Inamdar et al. generated 
the outlier effect [Figure 4].[16]
Figure  5 presents the meta‑analysis results of  the fetal 
adverse outcomes; the pooled event rate was 5.4% (95% 
CI = 0.035–0.083). The pooled event rate for maternal 
pregnancy‑related adverse events in pregnant patients was 
6.1% (95% CI = 0.040–0.093). The pooled event rate for 
maternal nonpregnancy‑related adverse events in pregnant 
patients was 11.9% (95% CI = 0.102–0.138). The quality 
of  evidence started low because analyzed studies were all 
observational. Symmetrical funnel plot was consistent with 
Figure 3: Meta-analysis result  of overall adverse events in pregnant patients undergoing ERCP
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the absence of  publication bias. No evidence of  publication 
bias by Egger’s regression test for all‑cause was found. 
The final quality of  evidence was high because no serious 
limitation was found in the NOS as shown in Table 2.
Subgroup analysis results were done by radiation 
exposure. Nine of  27 studies included both ERCP 
with radiation and NR‑ERCP. They did not specify the 
outcomes based on radiation exposure. Nine studies 
included only NR‑ERCP and another nine studies 
included radiation ERCP. NR‑ERCPs were performed 
using three different techniques: abdominal US‑guided 
ERCP, endoscopic ultrasound (EUS)‑guided ERCP, and 
choledochoscopy‑guided ERCP. Overall adverse events 
were less prevalent in the NR‑ERCP group  (pooled 
event rate of  17.6%, 95% CI  =  0.109–0.272) versus 
radiation ERCP group  (pooled event rate 21.6%, 95% 
CI = 0.154–0.294). There was no significant difference in 
the fetal adverse outcomes between the radiation ERCP 
group (pooled event rate 5.2%, 95% CI = 0.026–0.101) 
and the NR‑ERCP group (pooled event rate 6.2%, 95% 
CI = 0.027–0.137).
Maternal pregnancy‑related adverse outcomes were 
less prevalent in the radiation ERCP group  (pooled 
event rate 7.1%, 95% CI = 0.039–0.125) in comparison 
to the NR‑ERCP group  (pooled event rate 12.0%, 
95% CI  =  0.065–0.211). However, the overlap in CI 
makes the results less statistically significant. Maternal 
nonpregnancy‑related outcomes were more prevalent 
in the radiation ERCP group (pooled event rate 14.9%, 
95% CI  =  0.102–0.211) in comparison to 7.6%  (95% 
CI  =  0.038–0.145) in the NR‑ERCP group. Again, the 
CI overlap affects the statistical significance despite the 
low P value. All results were statistically significant with 
P value <0.01.
DISCUSSION
To our knowledge, this is the first meta‑analysis of  the 
ERCP outcomes in pregnancy and the first to provide a 
head‑to‑head comparison between radiation ERCP and 
NR‑ERCP. In this systematic review and meta‑analysis, 
we found ERCP to be a relatively safe procedure during 
pregnancy. Intraoperatively, no complications were 
reported. Maternal post‑ERCP adverse events included 
Figure 4: Overall adverse events in pregnant patients undergoing ERCP without outlier effect
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Figure 5: Fetal outcomes’ meta-analysis
pancreatitis, PSB, cholecystitis, and one incidence of  acute 
respiratory distress syndrome resulting in the only case 
of  maternal death. The rate of  ERCP‑related maternal 
adverse outcomes was found to be slightly higher than 
the usual ERCP outcomes.[16] ERCP was also associated 
with an increased risk of  preterm labor and preeclampsia, 
but there were no reported cases of  abortion, bleeding, 
or intrauterine fetal death. With regard to fetal outcomes, 
ERCP was found to be relatively safe on the fetus without 
any reported cases of  fetal congenital malformation or 
stillbirth, despite the increased risk of  preterm labor and 
low birth weight. A  subgroup analysis was performed 
to compare the outcomes of  radiation ERCP versus 
NR‑ERCP. NR‑ERCP had a higher safety profile in 
terms of  maternal nonpregnancy‑related outcomes with 
lower rates of  PEP and PSB. Regarding fetal outcomes, 
NR‑ERCP showed no superiority to radiation ERCP. No 
congenital malformations were reported in both groups. 
However, both groups had an increased risk of  preterm 
labor and intrauterine growth retardation.
Radiation exposure during fluoroscopy time in ERCP is 
used to visualize the anatomy of  the biliary tract and ensure 
safe and successful biliary cannulation, stone extraction, 
and sphincterotomy. Different NR‑ERCP techniques 
have recently been introduced to avoid possible radiation 
exposure fetal malformations. However, these techniques 
were not associated with better fetal outcomes in comparison 
to the radiation ERCP. This may be attributable to the fact 
that radiation exposure in ERCP is lower than the exposure 
needed to cause congenital fetal anomalies.[44] Fetal risk of  
anomalies, growth restriction, or abortion has not been 
reported with radiation exposure of  less than 50 mGy, a 
level above the range of  exposure in ERCP according to 
the American College of  Obstetrics and Gynecology.[44] In 
one study, the estimated fetal radiation exposure in 17 cases 
of  ERCP with limited fluoroscopy time  (range 1–48 s) 
is 0.4 mGy  (range 0.01–1.8 mGy).[11] Other factors that 
can affect the fetal absorbed dose of  irradiation include 
orientation of  the fetus, fetus size, procedure position, and 
body composition of  the mother.[45] Although most of  the 
fetal irradiation exposure comes from the radiation diffused 
from the maternal tissue, application of  a lead apron is 
still routinely recommended.[11] Several other strategies 
are recommended to reduce the fetal irradiation exposure 
and complications, including decreasing fluoroscopy time, 
minimizing exposure areas, and application of  electric 
grounding pad higher in the posterior thoracic wall level 
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to avoid transmission of  electric current to the fetus.[46,47] 
Gestational age at the time of  irradiation exposure is also 
crucial. Significant irradiation exposure before 16 weeks of  
gestational age has a higher risk of  intellectual disability.[48]
The NR‑ERCP group had lower rates of  PEP and PSB 
in comparison to the radiation ERCP. This finding is 
unexpected and should be interpreted cautiously due to CI 
overlap. It may be attributable to the fact that NR‑ERCP 
is a more sophisticated procedure which requires more 
equipment and a higher level of  expertise in endoscopy 
and is thus only performed by high‑volume practitioners. 
NR‑ERCP is achieved through empirical bile aspiration 
technique and can be done with imaging guidance. Bile 
aspiration technique allows confirmation of  common bile 
duct (CBD) cannulation and endoscopic sphincterotomy 
to be carried out without radiation, while imaging 
guidance can be provided by EUS, transabdominal US, 
or choledochoscopy. US allows recognition of  the CBD 
stone site, confirmation of  wire placement, and cannulation 
of  the CBD. An US contrast agent  (sulfur hexafluoride 
microbubbles) was injected through ERCP to improve 
visualization of  the CBD as an alternative to fluoroscopy 
in a single case report.[49] No fetal complications were 
reported in this case report; however, the safety profile 
of  this contrast material on the fetus is still unclear. 
US‑guided ERCP showed higher rate of  stone clearance 
in comparison to empirical NR‑ERCP  (89% vs 60%, 
P  <  0.05) and lower complication rates  (14% vs 3%, 
P < 0.05).[50] EUS can be carried out in the same session 
before ERCP to determine the number and site of  stones 
before NR‑ERCP is carried out with bile aspiration 
technique to clear the CBD.[51,52] Another way to confirm 
biliary cannulation and stone clearance without radiation 
is by insertion of  a choledochoscope through the working 
channel of  EGD to directly visualize the bile duct.[53] Due 
to the scarcity of  available literature, there are currently no 
available data that compare EUS‑guided ERCP or peroral 
choledochoscopy‑guided ERCP to empiric NR‑ERCP.
Two‑stage ERCP technique was introduced in a few 
reports. During pregnancy, NR‑ERCP with empiric biliary 
aspiration and CBD stenting is performed. After delivery, 
a repeat ERCP is performed to remove the stent and 
ensure CBD clearance.[31] Extensive experience in ERCP 
is required in this technique as stent placement without 
fluoroscopy might lead to the stent misplacement either in 
the gallbladder or before the stone. A postprocedural US 
is required to confirm the position of  the stent.
The following few points strengthen our confidence in the 
current meta‑analysis results. First, statistical heterogeneity 
was very low. Second, the quality of  the included studies 
was moderately high. Third, we found no evidence of  
publication bias. Nonetheless, we acknowledge several 
limitations. First, the risk of  selection bias could have 
resulted in underreporting of  ERCP adverse outcomes 
in pregnancy. Second, the duration of  follow‑up differed 
from one study to the other, and most patients were lost 
to follow‑up 1 month after delivery. Third, studies were 
performed at different locations around the world with 
varying levels of  expertise in endoscopy. Fourth, the 
heterogeneity in the NR‑ERCP techniques could have 
affected the outcomes.
In conclusion, our findings support the notion that ERCP 
should continue to be the procedure of  choice for bile 
duct decompression in pregnancy to prevent potentially 
life‑threatening complications to both mother and 
fetus. Nonradiation techniques may decrease the risk of  
nonpregnancy‑related outcomes, but do not impact fetal 
or pregnancy‑related outcomes.
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